|
Swiss Biotech Association Swiss Biotech Association – (SBA) is the industry association of the Swiss companies active in modern biotechnology. Corporte membership is open to coompanies concerned with biotechnology in either R&D, manufacturing , service or trade. SBA has more than 100 corporte members and enjoys healthy growth. The mambers are from all major sectors of the industry, such as pharmaceuticals (therapy and diagnostics), agribusiness, food, bio- and specialty chemicals, environment, reagents, and eqipment for biotechnological processes. SBA is a founding member of Swiss Biotech, the marketing alliance of Switzerland’s biotech industry. |
 |
| BioValley – Basel Area – where science drives business BioValley – Basel Area is a major center for pharmaceuticals, chemical and modern biotechnology industries, seat of Novartis, Roche and Actelion +++. More than 30’000 people are working in life sciences (incl. biotech) and about 40% of the world’s pharmaceutical industry is established in BioValley’s region. In the center of Europe, bordering to France (Alsace), Germany and Switzerland, Basel Area Business Development helps to:
BioValley – Basel Area |
 |
| BioAlps The BioAlps region, which encompasses the cantons of Geneva, Vaud, Valais, Neuchâtel and Fribourg offers leading edge competency in pharmaceuticals, chemistry, biotechnology, micro-technology, precision instruments and medical devices. BioAlps is an association whose aim is to promote Western Switzerland as a European pole in matters of life sciences, to promote its education and research institutions as well as the enterprises related to the sector. The objective is to create a platform, which makes it possible to increase both the contact and visibility of the region’s institutions on a national and international level. It also involves favouring collaboration with enterprises and technological transfer. Apart from the five member cantons, the programme is also supported by the region’s major training and research institutions:
|
 |
|
Biopolo Ticino – the working net in life sciences The Biopolo Ticino has just shortly concluded its first year of operations. The idea to create a technological hub for the life sciences in the Italian speaking part of Switzerland followed a natural development that the region has been undergoing during the last couple of years. The objectives of the Biopolo Ticino are to catalyze and sustain the local integration of technology and knowledge in the field of the life sciences, with the final goal of creating a cluster with high visibility. Furthermore, its activities are focusing on promoting the integrated Ticino life science competencies outside the local boundaries, and to promote/coach/attract interesting and interested entities to Ticino. Its aim is to become a one-stop shop and a portal for the life sciences in, from and to Ticino. Besides the main networking activities the Biopolo Ticino is able to offer specific coaching and support services along the value chain (e.g. tech transfer, tech scouting, creation of business plans). Also in Ticino the biopharmaceutical and chemical sectors are successful and very important value-creating industrial sectors for the regional economy. For example, in 2003 Helsinn, a local pharmaceutical company, together with MGI pharma Inc, obtained the FDA approval for an anti-emetic drug in the USA. In addition, the territory also offers a number of production plants that have been inspected and approved by the FDA. However the main focus of the local life science activities are industrial, service and less R&D driven. Contact information: |
 |
|
Greater Zurich MedNet Greater Zurich Area AG as a marketing organization facilitates the market entry for foreign companies in Switzerland and supports them in their process to set up their local company as well as to establish their network in the Zurich Life sciences community. Zurich MedNet is the locally and internationally integrated life science cluster in the Greater Zurich Area. It includes more than 430 medical and biotech companies, universities, technical collages and technology transfer institutions. The Greater Zurich Area features numerous diversified research parks, business parks and several incubators to support a prosperous development of biotechnology companies. |
 |
|
Business Guide to Switzerland Profile to follow shortly. |
 |
|
Swiss Biotech – Reaching the Peak of Innovation Swiss Biotech unites the various Biotech Regions of Switzerland. The marketing alliance was founded in conjunction with Swiss Exchange Group SWX, and the Swiss Biotech Association. In a targeted manner, the alliance raises Switzerland’s profile as an economic centre and positons the biotech regions as innovative and entrepreneurial focal points for research, production and services. Swiss Biotech wants to spread the message of Switzerland as one of the top biotech locations in the world. This will be achieved by presenting a comprehensive picture of biotechnology including all pillars of the value chain. The bases for success in biotechnology are the critical mass of research institutes and rapid technology transfer. The vicinity to industry and well-trained workforce is another key-driver for success. Recently, Swiss regions opened a series of ‘Biotech-Parks’, thus enabling to offer increased value to companies. Swiss Biotech |
 |